K46-24722-90310

3 vaccinations 3 coded responses 39 check-ins 3 free-text entries 3 call cases

Sex: Female
Age at first dose: 31-35
ZIP prefix: 787 / TX
Registered: 2021-03-25

Relationship: Self
Race: White
Ethnicity: Not Hispanic or Latino

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-03-25
Registered in v-safe
2021-03-25
Dose 1 — Moderna
2021-03-25
Health check-in — day 0, dose 1
Feeling: Fair · Site: Pain · Fatigue or tiredness

Adult check-in
2021-03-26
Health check-in — days 1–6 daily, dose 1
Feeling: Fair · Site: Pain · Fatigue or tiredness · Be unable to do your normal daily activities

Adult check-in
2021-03-27
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Site: Pain · None

Adult check-in
2021-03-28
Health check-in — days 1–6 daily, dose 1
Feeling: Fair · Site: Pain · Rash, not including the immediate area around the injection site

Adult check-in
2021-03-29
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-03-30
Health check-in — days 1–6 daily, dose 1
Feeling: Fair · Headache

Adult check-in
2021-03-31
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-04-01
Health check-in — day 7, dose 1
Feeling: Good · None

Adult check-in
2021-04-08
Health check-in — day 14, dose 1
Feeling: Good

Adult check-in
2021-04-15
Health check-in — day 21, dose 1
Feeling: Good

Adult check-in
2021-04-22
Dose 2 — Moderna
2021-04-22
Health check-in — day 0, dose 2
Feeling: Good · Fatigue or tiredness

Adult check-in
2021-04-23
Health check-in — days 1–6 daily, dose 2
Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Diarrhea · Be unable to do your normal daily activities

Adult check-in
2021-04-24
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Site: Pain, Redness, Swelling · Fatigue or tiredness

Adult check-in
2021-04-25
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Site: Pain, Redness, Swelling · None

Adult check-in
2021-04-27
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-04-28
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-04-29
Health check-in — day 7, dose 2
Feeling: Good · None

Adult check-in
2021-05-06
Health check-in — day 14, dose 2
Feeling: Good

Adult check-in
2021-05-13
Health check-in — day 21, dose 2
Feeling: Good

Adult check-in
2021-05-20
Health check-in — day 28, dose 2
Feeling: Good

Adult check-in
2021-05-27
Health check-in — day 35, dose 2
Feeling: Good

Adult check-in
2021-06-03
Health check-in — day 42, dose 2
Feeling: Good

Adult check-in
2021-07-22
Health check-in — 3 months, dose 2
Feeling: Good

Adult check-in
2021-10-21
Health check-in — 6 months, dose 2
Feeling: Good

Adult check-in
2021-12-14
Dose 3 — Moderna
2021-12-15
Health check-in — days 1–6 daily, dose 3
Feeling: Good · Site: Pain, Swelling · Fever · Chills, Fatigue or tiredness

Adult check-in
2021-12-16
Health check-in — days 1–6 daily, dose 3
Feeling: Fair · Site: Pain, Swelling · Headache, Fatigue or tiredness

Adult check-in
2021-12-17
Health check-in — days 1–6 daily, dose 3
Feeling: Good · None

Adult check-in
2021-12-18
Health check-in — days 1–6 daily, dose 3
Feeling: Fair · Fatigue or tiredness · Be unable to do your normal daily activities

Adult check-in
2021-12-19
Health check-in — days 1–6 daily, dose 3
Feeling: Good · Fatigue or tiredness

Adult check-in
2021-12-20
Health check-in — days 1–6 daily, dose 3
Feeling: Good · Fatigue or tiredness

Adult check-in
2021-12-21
Health check-in — day 7, dose 3
Feeling: Good · None

Adult check-in
2021-12-28
Health check-in — day 14, dose 3
Feeling: Good

Adult check-in
2022-01-04
Health check-in — day 21, dose 3
Feeling: Good

Adult check-in
2022-01-11
Health check-in — day 28, dose 3
Feeling: Good

Adult check-in
2022-01-18
Health check-in — day 35, dose 3
Feeling: Good

Adult check-in
2022-01-25
Health check-in — day 42, dose 3
Feeling: Good

Adult check-in
2022-03-15
Survey response — 3 months, dose 3
MedDRA: Foetal growth restriction, Placental insufficiency — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit

Free text: Placental insufficiency and severe IUGR

MedDRA releases: 2024-11 · check-in free text available
2022-03-15
Report sent to call center — 3 months, dose 3
Get care from a doctor or other healthcare professional

Telehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
2022-03-17
Call 1 — Left Voicemail
2022-06-14
Survey response — 6 months, dose 3
MedDRA: Death neonatal, HELLP syndrome, Phaeochromocytoma, Pre-eclampsia — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit, Hospitalization

Free text: preeclampsia, HELLP syndrome, neonatal loss, Pheochromocytoma

MedDRA releases: 2024-11 · check-in free text available
2022-06-14
Report sent to call center — 6 months, dose 3
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Telehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · Hospitalization · 1 call case(s)
2022-06-15
Call 2 — Left Voicemail
2022-06-15
Call 1 — Left Voicemail
2022-06-15
Call successful
Reported to VAERS voluntarily prior to GDIT contact
2022-06-15
Call successful
Reported to VAERS voluntarily prior to GDIT contact
2022-12-14
Survey response — 12 months, dose 3
MedDRA: Adrenalectomy, Phaeochromocytoma — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Hospitalization

Free text: Pheochromocytoma and right adrenalectomy

MedDRA releases: 2024-11 · check-in free text available
2022-12-14
Report sent to call center — 12 months, dose 3
Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional

Hospitalization · 1 call case(s)
2022-12-15
Call 1 — Left Voicemail

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-03-25	Moderna
2	2021-04-22	Moderna
3	2021-12-14	Moderna	No

Call center

Reported	Outcome	VAERS-related outcome
2022-03-15	Successful 2022-06-15	Reported to VAERS voluntarily prior to GDIT contact
2022-06-14	Successful 2022-06-15	Reported to VAERS voluntarily prior to GDIT contact
2022-12-14	Unsuccessful	Reported to VAERS voluntarily prior to GDIT contact

Free text

Release 11 — 3 months, dose 3

2022-03-15

Symptoms: Placental insufficiency and severe IUGR

Release 12 — 6 months, dose 3

2022-06-14

Symptoms: preeclampsia, HELLP syndrome, neonatal loss, Pheochromocytoma

Release 12 — 12 months, dose 3

2022-12-14

Symptoms: Pheochromocytoma and right adrenalectomy

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Adrenalectomy	·	·	✓
SD	Death neonatal	·	·	✓
SD	Foetal growth restriction	·	·	✓
SD	HELLP syndrome	·	·	✓
SD	Phaeochromocytoma	·	·	✓
SD	Placental insufficiency	·	·	✓
SD	Pre-eclampsia	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release